Logo image of PROT.OL

PROTECTOR FORSIKRING ASA (PROT.OL) Stock Fundamental Analysis

OSL:PROT - Euronext Oslo - NO0010209331 - Common Stock - Currency: NOK

505  +41 (+8.84%)

Fundamental Rating

5

Taking everything into account, PROT scores 5 out of 10 in our fundamental rating. PROT was compared to 38 industry peers in the Insurance industry. PROT has an average financial health and profitability rating. PROT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year PROT was profitable.
In the past year PROT has reported a negative cash flow from operations.
Each year in the past 5 years PROT has been profitable.
The reported operating cash flow has been mixed in the past 5 years: PROT reported negative operating cash flow in multiple years.
PROT.OL Yearly Net Income VS EBIT VS OCF VS FCFPROT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

1.2 Ratios

PROT has a better Return On Assets (6.68%) than 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 31.52%, PROT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.75%, PROT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PROT is significantly above the industry average of 2.06%.
Industry RankSector Rank
ROA 6.68%
ROE 31.52%
ROIC 7.75%
ROA(3y)7.22%
ROA(5y)6.78%
ROE(3y)32.76%
ROE(5y)33%
ROIC(3y)7.88%
ROIC(5y)6.75%
PROT.OL Yearly ROA, ROE, ROICPROT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

PROT has a Profit Margin of 14.25%. This is amongst the best in the industry. PROT outperforms 84.62% of its industry peers.
PROT's Profit Margin has declined in the last couple of years.
PROT has a better Operating Margin (21.23%) than 87.18% of its industry peers.
In the last couple of years the Operating Margin of PROT has declined.
Industry RankSector Rank
OM 21.23%
PM (TTM) 14.25%
GM N/A
OM growth 3Y-8.32%
OM growth 5YN/A
PM growth 3Y-15.26%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PROT.OL Yearly Profit, Operating, Gross MarginsPROT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

4

2. Health

2.1 Basic Checks

PROT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PROT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for PROT has been increased compared to 5 years ago.
The debt/assets ratio for PROT has been reduced compared to a year ago.
PROT.OL Yearly Shares OutstandingPROT.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PROT.OL Yearly Total Debt VS Total AssetsPROT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

PROT has an Altman-Z score of 2.21. This is not the best score and indicates that PROT is in the grey zone with still only limited risk for bankruptcy at the moment.
PROT has a better Altman-Z score (2.21) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that PROT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.46, PROT is in the better half of the industry, outperforming 74.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 2.21
ROIC/WACC0.92
WACC8.43%
PROT.OL Yearly LT Debt VS Equity VS FCFPROT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

A Current Ratio of 0.06 indicates that PROT may have some problems paying its short term obligations.
PROT has a better Current ratio (0.06) than 74.36% of its industry peers.
PROT has a Quick Ratio of 0.06. This is a bad value and indicates that PROT is not financially healthy enough and could expect problems in meeting its short term obligations.
PROT has a better Quick ratio (0.06) than 74.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
PROT.OL Yearly Current Assets VS Current LiabilitesPROT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

PROT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.45%, which is quite impressive.
Measured over the past 5 years, PROT shows a small growth in Earnings Per Share. The EPS has been growing by 7.66% on average per year.
Looking at the last year, PROT shows a very strong growth in Revenue. The Revenue has grown by 20.81%.
PROT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.85% yearly.
EPS 1Y (TTM)36.45%
EPS 3Y7.66%
EPS 5YN/A
EPS Q2Q%63.64%
Revenue 1Y (TTM)20.81%
Revenue growth 3Y27.1%
Revenue growth 5Y22.85%
Sales Q2Q%7.74%

3.2 Future

PROT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.18% yearly.
PROT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.78% yearly.
EPS Next Y13.15%
EPS Next 2Y14.67%
EPS Next 3Y12.18%
EPS Next 5YN/A
Revenue Next Year15.85%
Revenue Next 2Y12.5%
Revenue Next 3Y13.78%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PROT.OL Yearly Revenue VS EstimatesPROT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
PROT.OL Yearly EPS VS EstimatesPROT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20 25

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.78, PROT is valued on the expensive side.
Based on the Price/Earnings ratio, PROT is valued a bit more expensive than the industry average as 74.36% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.30, PROT is valued at the same level.
Based on the Price/Forward Earnings ratio of 20.80, the valuation of PROT can be described as rather expensive.
Based on the Price/Forward Earnings ratio, PROT is valued more expensive than 87.18% of the companies in the same industry.
PROT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 22.78
Fwd PE 20.8
PROT.OL Price Earnings VS Forward Price EarningsPROT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PROT.OL Per share dataPROT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

PROT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of PROT may justify a higher PE ratio.
A more expensive valuation may be justified as PROT's earnings are expected to grow with 12.18% in the coming years.
PEG (NY)1.73
PEG (5Y)N/A
EPS Next 2Y14.67%
EPS Next 3Y12.18%

More info and screens

3

5. Dividend

5.1 Amount

PROT has a Yearly Dividend Yield of 1.94%.
Compared to an average industry Dividend Yield of 4.56, PROT's dividend is way lower than its industry peers. On top of this 89.74% of the companies listed in the same industry pay a better dividend than PROT!
Compared to an average S&P500 Dividend Yield of 2.35, PROT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.94%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

36.19% of the earnings are spent on dividend by PROT. This is a low number and sustainable payout ratio.
DP36.19%
EPS Next 2Y14.67%
EPS Next 3Y12.18%
PROT.OL Yearly Income VS Free CF VS DividendPROT.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B
PROT.OL Dividend Payout.PROT.OL Dividend Payout, showing the Payout Ratio.PROT.OL Dividend Payout.PayoutRetained Earnings

More info and screens

PROTECTOR FORSIKRING ASA

OSL:PROT (7/11/2025, 7:00:00 PM)

505

+41 (+8.84%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)07-11 2025-07-11
Earnings (Next)10-23 2025-10-23
Inst Owners35.41%
Inst Owner ChangeN/A
Ins Owners1.74%
Ins Owner ChangeN/A
Market Cap41.66B
Analysts84.44
Price Target397.8 (-21.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.94%
Yearly Dividend9
Dividend Growth(5Y)N/A
DP36.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.32%
Min Revenue beat(2)-4.49%
Max Revenue beat(2)1.85%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-31.22%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.86%
Valuation
Industry RankSector Rank
PE 22.78
Fwd PE 20.8
P/S 3.26
P/FCF N/A
P/OCF N/A
P/B 7.2
P/tB 7.35
EV/EBITDA N/A
EPS(TTM)22.17
EY4.39%
EPS(NY)24.28
Fwd EY4.81%
FCF(TTM)-3.64
FCFYN/A
OCF(TTM)-2.79
OCFYN/A
SpS155.02
BVpS70.1
TBVpS68.7
PEG (NY)1.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.68%
ROE 31.52%
ROCE 10.18%
ROIC 7.75%
ROICexc 7.81%
ROICexgc 8.48%
OM 21.23%
PM (TTM) 14.25%
GM N/A
FCFM N/A
ROA(3y)7.22%
ROA(5y)6.78%
ROE(3y)32.76%
ROE(5y)33%
ROIC(3y)7.88%
ROIC(5y)6.75%
ROICexc(3y)8%
ROICexc(5y)6.86%
ROICexgc(3y)8.73%
ROICexgc(5y)8.12%
ROCE(3y)10.35%
ROCE(5y)8.87%
ROICexcg growth 3Y-2.94%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.7%
ROICexc growth 5YN/A
OM growth 3Y-8.32%
OM growth 5YN/A
PM growth 3Y-15.26%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z 2.21
F-Score4
WACC8.43%
ROIC/WACC0.92
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.62%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.45%
EPS 3Y7.66%
EPS 5YN/A
EPS Q2Q%63.64%
EPS Next Y13.15%
EPS Next 2Y14.67%
EPS Next 3Y12.18%
EPS Next 5YN/A
Revenue 1Y (TTM)20.81%
Revenue growth 3Y27.1%
Revenue growth 5Y22.85%
Sales Q2Q%7.74%
Revenue Next Year15.85%
Revenue Next 2Y12.5%
Revenue Next 3Y13.78%
Revenue Next 5YN/A
EBIT growth 1Y32.43%
EBIT growth 3Y16.52%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.95%
FCF growth 3Y10.04%
FCF growth 5Y-2.19%
OCF growth 1Y-124.06%
OCF growth 3Y10.09%
OCF growth 5Y-1.74%